Satellos Bioscience Inc. Common Stock Cash Flow-to-Debt Ratio
Satellos Bioscience Inc. Common Stock cash flow-to-debt ratio. Satellos Bioscience Inc. Common Stock (MSLE) has a Cash Flow-to-Debt Ratio of -1.34x as of June 2026, meaning its operating cash flow of $-7.83 Million could theoretically repay -1% of its total liabilities ($5.85 Million) in one year. See Satellos Bioscience Inc. Common Stock (MSLE) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Satellos Bioscience Inc. Common Stock (2007–2025)
Cash flow-to-debt ratio of Satellos Bioscience Inc. Common Stock from 2007 to 2025. Historical debt coverage capacity for Satellos Bioscience Inc. Common Stock across 18 annual periods. Also explore net asset momentum of Satellos Bioscience Inc. Common Stock to track the company's year-over-year net asset growth rate.
Satellos Bioscience Inc. Common Stock Cash Flow-to-Debt Ratio by Year (2007–2025)
Satellos Bioscience Inc. Common Stock cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Satellos Bioscience Inc. Common Stock. For the full cash flow conversion analysis, see Satellos Bioscience Inc. Common Stock (MSLE) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.75x | $-23.60 Million | $4.11 Million | ▼ -18.6% |
| 2024 | -4.84x | $-17.40 Million | $3.59 Million | ▼ -21.8% |
| 2023 | -3.98x | $-14.42 Million | $3.62 Million | ▼ -96.8% |
| 2022 | -2.02x | $-5.66 Million | $2.80 Million | ▲ +15.5% |
| 2021 | -2.39x | $-3.95 Million | $1.65 Million | ▼ -89.3% |
| 2020 | -1.26x | $-1.66 Million | $1.32 Million | ▲ +54.4% |
| 2019 | -2.77x | $-2.30 Million | $829.64K | ▼ -101.4% |
| 2018 | -1.38x | $-1.10 Million | $800.13K | ▲ +85.7% |
| 2016 | -9.64x | $-1.34 Million | $139.24K | ▲ +64.1% |
| 2015 | -26.87x | $-3.09 Million | $114.92K | ▼ -1395.5% |
| 2014 | -1.80x | $-2.71 Million | $1.51 Million | ▼ -25.6% |
| 2013 | -1.43x | $-3.57 Million | $2.50 Million | ▲ +50.1% |
| 2012 | -2.86x | $-2.77 Million | $965.94K | ▲ +62.2% |
| 2011 | -7.59x | $-1.93 Million | $254.62K | ▲ +17.1% |
| 2010 | -9.15x | $-2.68 Million | $293.31K | ▼ -39.2% |
| 2009 | -6.58x | $-2.12 Million | $323.03K | ▼ -22.2% |
| 2008 | -5.38x | $-2.08 Million | $387.29K | ▼ -7.7% |
| 2007 | -5.00x | $-3.90 Million | $780.80K | — |